Rivia

Rivia is a Zurich-based technology company building a data engine that powers the future of clinical trial intelligence. Rivia was founded on the belief that new drugs can be brought to market more successfully with a fraction of today’s capital. Over the past two years, European and US based biotechs running global cl

Rivia is a company in vc portfolio based in Zurich, founded in 2022.

Profile

Rivia is a Zurich-based technology company building a data engine that powers the future of clinical trial intelligence. Rivia was founded on the belief that new drugs can be brought to market more successfully with a fraction of today’s capital. Over the past two years, European and US based biotechs running global clinical trials on Rivia have demonstrated measurable impact, from earlier understanding of therapeutic potential to significantly more efficient trial execution. In the years ahead, the company will scale its platform and embedded intelligence to help bring groundbreaking therapies to market faster.

The company sits in the vc portfolio segment, where it competes on its core product or service.

Its base of operations is Zurich.

Its current recorded stage is Invested 2025.

The company reports a headcount in the 1-10 range.

Website: rivia.ch